Experimental evaluation demonstrates reduced hallucinations and improved faithfulness across domain-specific language models, highlighting an efficient path to safe enterprise retrieval deployment.
Retrieval-Augmented Generation (RAG) has become the gold standard paradigm for deploying Large Language Models (LLMs) in knowledge-intensive and high-stakes domains such as biomedical inquiry, financial compliance, and legal reasoning. Despite providing external grounding documents, LLMs continue to exhibit insidious factual hallucinations—either by fabricating plausible-sounding unsupported assertions or by ignoring conflicting retrieved evidence in favor of memorized parametric training biases. Existing mitigation approaches, such as full-parameter fine-tuning or iterative self-reflection prompting, incur prohibitive computational costs and excessive inference latency. In this paper, we propose CAL-RAG (Context-Aware Low-Rank Calibration for RAG), a parameter-efficient fine-tuning and decoding calibration framework designed to enforce strict contextual faithfulness without compromising generative fluency. CAL-RAG introduces a dual-channel Low-Rank Adaptation (LoRA) mechanism: a Context-Grounded Adapter that measures token-level semantic consistency against retrieved evidence chunks, and an Entropy-Gated Decoding Controller that dynamically modulates vocabulary probability distributions during autoregressive generation based on cross-attention dispersion. We conduct extensive empirical evaluations across three challenging domain benchmarks: BioASQ (biomedical), FinQA (financial reasoning), and LegalBench (legal clause interpretation), utilizing open-source LLM backbones (Llama-3-8B, Mistral-7B-Instruct, and Gemma-7B). CAL-RAG reduces factual hallucination rates by 43.7% relative to standard RAG baselines while improving Faithfulness Score from 0.642 to 0.891 and answer accuracy by +11.8% F1. Remarkably, CAL-RAG adds only 0.4% trainable parameters and introduces less than 6.5 ms token latency overhead, making it highly suitable for enterprise production deployment.
No takes yet. Share an insight, caveat, or question.
Tawar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: